Your Article Summary
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Corporate News Releases - The Healthcare Sales & Marketing Network, 06/27/06
Lumenis Ltd., a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, announced that it has received exclusive worldwide licensing rights for SRT(TM), a new laser therapy for selectively treating retinal diseases. These rights include licenses issued to Lumenis by Medizinisches Laserzentrum Lubeck GmbH, Massachusetts General Hospital and Professor Reginald Birngruber
| Previous Article | Next Article |
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Spherix announces full-scale production of pharmaceutical tagatose
Spherix, 06/24/09
Thermophilic ethanologenesis: future prospects for second-generation bioethanol production
Trends in Biotechnology , 06/30/09
Antiplasmodial activity of extracts from seven medicinal plants used in malaria treatment in Cameroon
Journal of Ethnopharmacology , 06/15/09
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Wyeth Winds Up With New Pristiq Campaign
PharmExec, 06/11/09
MediciNova and Avigen Confirm Understanding for Key Terms for a Business Combination
Avigen, 06/26/09
Emerging markets & emerging needs: Developing countries vaccine manufacturers' perspective & its current status
Biologicals, 06/08/09
Article Search
Sponsor


See Latest Articles


